SEARCH RESULTS FOR: (*EPP Heating Room*)(17061 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Filters
Sort By
10
Results Per Page
10
Results/Pg
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

U/P Root Canal Powder - D6870011430FG0

U/P Root Canal Powder, Powder (1/2 oz/15 g)
DENTSPLY INTERNATIONAL INC.
0011430FG
Not in Commercial Distribution

  • D6870011430FG0 ()

  • 1 Bottle Powder (15 g)
  • Weight: 15 Gram
0011430FG

  • Hygroscopic dental cement

U/P Root Canal Powder - D6870011616FG0

U/P Root Canal Powder, Medium Set
DENTSPLY INTERNATIONAL INC.
0011616FG
Not in Commercial Distribution

  • D6870011616FG0 ()

  • 30 Capsules
0011616FG

  • Hygroscopic dental cement

U/P Root Canal Powder - D6870011427FG1

U/P Root Canal Powder, 1 Bottle
DENTSPLY INTERNATIONAL INC.
0011427FG
Not in Commercial Distribution

  • D6870011427FG1 ()
  • D6870011427FG0 ()

  • 1 Bottle (30 Capsules)
0011427FG

  • Hygroscopic dental cement

LACRIFLOW CL - 04540778171398

The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube

LACRIFLOW CL - 04540778171381

The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube

LACRIFLOW - 04540778140875

The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube

LACRIFLOW - 04540778140868

The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube

Mi1250 SYNCHRONY 2 FLEX34 S-Vector Magnet - 09008737415440

Cochlear Implant
Med-El Elektromedizinische Geräte Gesellschaft m.b.H.
41544
In Commercial Distribution

  • 09008737415440 ()
41548

  • Cochlear implant system

Mi1250 SYNCHRONY 2 FLEX20 S-Vector Magnet - 09008737395490

'Cochlear Implant
Med-El Elektromedizinische Geräte Gesellschaft m.b.H.
39549
In Commercial Distribution

  • 09008737395490 ()
39577

  • Cochlear implant system electrode array assembly

Mi1250 SYNCHRONY 2 FLEX26 S-Vector Magnet - 09008737395476

Cochlear Implant
Med-El Elektromedizinische Geräte Gesellschaft m.b.H.
39547
In Commercial Distribution

  • 09008737395476 ()
39575

  • Cochlear implant system electrode array assembly
< 1 ... 59 60 61 62 63 ... 1000 >